Latest

Alzheimer’s disease

Featured Genetics Neurology Neuroscience

·June 17, 2026·9 min read

Alzheimer’s Protein APP Acts as Vital Shield for Neurons

A new study reveals that amyloid precursor protein (APP), long studied merely as the source of toxic plaques in Alzheimer's disease, serves a vital protective role as a cellular guardian.

Featured Neurology Neuroscience

·June 16, 2026·10 min read

Retinal Photos and AI Predict Early Alzheimer’s Risk

Routine, low-cost retinal photographs can accurately predict primary biological and lifestyle risk factors for Alzheimer’s disease.

Featured Neurology Neuroscience

·June 15, 2026·8 min read

Behavioral Mapping Tames Hallucinations in Alzheimer’s Psychosis

A new report outlines a critical, person-centered framework to manage Alzheimer's-related psychosis without relying on high-risk sedatives.

Featured Neurology Neuroscience

·June 14, 2026·11 min read

Psilocybin Unlocks Lost Memories in an Alzheimer’s Patient

A new study demonstrates that a single dose of psilocybin-containing mushrooms temporarily restored spontaneous speech, motor independence, and urinary continence in an 80-year-old woman with advanced Alzheimer's disease.

Featured Neurology Neuroscience

·June 9, 2026·11 min read

Glucosamine Supplement Linked to Accelerated Alzheimer’s Progression

Analyzing 12 years of deidentified patient electronic records using AI, researchers discovered that glucosamine use among individuals with Mild Cognitive Impairment (MCI) is associated with a 25% higher likelihood of progressing to full dementia, alongside a 25% spike in mortality for established Alzheimer’s patients.

Featured Genetics Neurology Neuroscience

·June 8, 2026·10 min read

New Compound Blocks Nerve Cell Death in Alzheimer’s

A new study introduces "Compound 10" as a novel therapeutic agent designed to preserve neural energy networks.

Featured Genetics Neurology Neuroscience

·June 7, 2026·9 min read

Microglial State Transitions Dictate Alzheimer’s

A new study identifies a critical microglial state transition that determines whether pathology progresses toward clinical dementia.

Electrophysiology Featured Neuroscience

·June 1, 2026·11 min read

Neuropixels Opto Probe Rewrites Brain Data

A new study introduces Neuropixels Opto, an ultra-thin silicon probe narrower than a human hair capable of simultaneously monitoring and manipulating hundreds of individual neurons deep within the brain.

Featured Neurology Neuroscience

·May 29, 2026·12 min read

The Brain Waste System Disrupted by Alzheimer’s Mapped

A new study leverages an elegant genetic engineering technique to track the exact routes metabolic debris uses to exit the central nervous system.

Featured Neurology Neuroscience

·May 28, 2026·9 min read

Neuronal AcCoA Signaling Linked to Autophagy Defects in Alzheimer’s

Neurons and glial cells utilize a specialized metabolic mechanism centered on leucine-derived acetyl-coenzyme A (AcCoA) to regulate the master growth hub, mTORC1.

Featured Genetics Neurology Neuroscience

·May 20, 2026·10 min read

Alzheimer’s Risk Gene May Drive Aggressive ALS

The APOE ε4 variant heavily influences how toxic phosphorylated TDP-43 (pTDP-43) pathology migrates across the central nervous system.

$This shows a brain made of pills.$

Featured Neurology Neuroscience

·May 18, 2026·9 min read

New Math Method Inflates Alzheimer’s Drug Success by 29x

A critical research lette exposes severe flaws in "quantile aggregation", a statistical technique recently used by pharmaceutical researchers to evaluate the drug donanemab.